Is Prophylaxis the Only Way Out for Cytokine Release Syndrome Associated With Chimeric Antigen T-cell Therapy?

Chimeric antigen receptor T-cell (CAR-T) therapy is a new advancement in hematology and oncology with its use in treating many refractory malignancies. Cytokine release syndrome (CRS) is CAR-T's clinically hazardous side effect, ranging from mild to life-threatening events. It was one of the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dave, Prashil, Pallares Vela, Elisa, Cancarevic, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489777/
https://www.ncbi.nlm.nih.gov/pubmed/34650883
http://dx.doi.org/10.7759/cureus.17709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489777/
https://www.ncbi.nlm.nih.gov/pubmed/34650883
http://dx.doi.org/10.7759/cureus.17709

Ejemplares similares